ProCE Banner Activity

Expert Analysis: Insights for International Clinicians on New Data From CROI 2020

Conference Coverage
Text Module

Experts review new HIV study data on long-acting treatment, switch strategies, care linkage, and coinfection management from CROI 2020 that will affect practice for international clinicians managing HIV patient care around the world.

Released: April 21, 2020

Expiration: April 20, 2021

Share

Faculty

Josep M. Llibre

Josep M. Llibre, MD, PhD

Senior Consultant
Infectious Diseases Division
Fight Infections Foundation
University Hospital Germans Trias
Badalona, Barcelona, Spain

Laura Waters

Laura Waters, FRCP, MD

Consultant Physician, HIV/GU Medicine
Mortimer Market Centre
CNWL NHS Trust
London, United Kingdom

Provided by

Provided by the USF Health

ProCE Banner

Supporters

This activity is supported by educational grants from

Gilead

ViiV Healthcare

Target Audience

This program is intended for physicians, pharmacists, and other healthcare providers who care for patients with HIV.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Devise management strategies based on the results of recent clinical studies of established ARV agents in HIV-infected patients
  • Appropriately counsel patients regarding emerging data on potential adverse events associated with ART
  • Apply data from studies optimizing prevention and treatment of coinfections among people with HIV infection

Faculty Disclosure

Primary Author

Josep M. Llibre, MD, PhD

Senior Consultant
Infectious Diseases Division
Fight Infections Foundation
University Hospital Germans Trias
Badalona, Barcelona, Spain

Josep M. Llibre, MD, PhD, has disclosed that he has received consulting fees from and has served on advisory boards or panels for Gilead Sciences, Janssen, MSD, and ViiV.

Laura Waters, FRCP, MD

Consultant Physician, HIV/GU Medicine
Mortimer Market Centre
CNWL NHS Trust
London, United Kingdom

Laura Waters, MD, has disclosed that she has received consulting fees from Cipla, Gilead Sciences, Janssen, Merck, Mylan, and ViiV Healthcare.

Staff Disclosure

Staff

Jennifer M. Blanchette, Ph.D.

Clinical Editor
Clinical Care Options, LLC

Jennifer Blanchette, PhD, has no relevant conflicts of interest to report.

Megan Cartwright, PhD

Senior Clinical Editor

Megan Cartwright, PhD, has no relevant conflicts of interest to report.

Edward King, M.A.

Vice President, Editorial
Clinical Care Options, LLC

Edward King, MA, has no relevant conflicts of interest to report.

Additional Information

Program Medium

This program has been made available online.

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

 

Goal


The goal of this activity is to improve learners’ competence in translating the most clinically significant data from an important scientific meeting into practical management strategies for persons at risk of or infected with HIV.